Radioprotective effect of melatonin in patient with rectal cancer
Phase 2
- Conditions
- Condition 1: rectal cancer. Condition 2: radiation injury.Benign neoplasm: RectumExposure to ionizing radiation
- Registration Number
- IRCT2016021626586N1
- Lead Sponsor
- Babol University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
60 patients with rectal cancer; aged 40 to 60 years with radiotherapy and chemotherapy same regime that still have not done surgery Exclusion criteria: patients with autoimmune diseases (purpura); von Willebrand's disease; patients that of aspirin drugs; sulfadiazine; daunorubicin use; individuals who previously had chemotherapy or radiotherapy; people who have a history of depression or suicidal feeling
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Thrombocytopenia. Timepoint: before beginning treatment and at the end of treatment. Method of measurement: CBC.
- Secondary Outcome Measures
Name Time Method Thrombocytopenia. Timepoint: before beginning treatment and at the end of treatment. Method of measurement: CBC.